Get started
Author

Ana Batlle‐López

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies
2014 · J. P. Vaque, N. Martinez, et al. · Haematologica · 61
PDF
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
2017 · Anna Puiggros, Rosa Collado, et al. · Oncotarget · 51
PDF
Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): A short review
2014 · Almudena Pérez-Rodríguez, Esther Lourés, et al. · Thrombosis Research · 41
Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells
2019 · María G. Cortiguera, Lorena García-Gaipo, et al. · Scientific Reports · 33
PDF
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
2016 · Ana Batlle-López, Sonia González de Villambrosía, et al. · Oncotarget · 33
PDF
R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group
2021 · Juan‐Manuel Sancho, Rubén Fernández‐Alvarez, et al. · Cancer Medicine · 30
PDF
High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle
2014 · Juan M. Caraballo, Juan C. Acosta, et al. · Oncotarget · 26
PDF
Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus
2013 · A Batlle-López, M G Cortiguera, et al. · Oncogene · 19
Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options
2016 · Ana Battle-Lopez, Sonia Gonzalez de Villambrosia, et al. · Expert Review of Anticancer Therapy · 15
MYC as therapeutic target in leukemia and lymphoma
2015 · Javier Leon, Maria G Cortiguera, et al. · Blood and Lymphatic Cancer Targets and Therapy · 10
PDF
Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors
2023 · Carmen Álvarez-Reguera, Diana Prieto-Peña, et al. · European Journal of Internal Medicine · 5
COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health Decision
2021 · David San Segundo, Alejandra Comins-Boo, et al. · Vaccines · 4
PDF
Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance
2017 · Maria Joao Baptista, Isabel Granada, et al. · American Journal of Hematology · 2
PDF
The epigenetic regulator CTCF modulates BCL6 in lymphoma
2015 · Ana Batlle-López, María G. Cortiguera, et al. · Oncoscience · 2
PDF
A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome
2014 · Almudena Pérez-Rodríguez, Ana Batlle-López, et al. · Thrombosis and Haemostasis · 2
CTCF Regulates Erythroid Differentiation Through Control of Core Erythroid Transcription Factors
2026 · Lorena García-Gaipo, Vanessa Junco, et al. · Biomolecules
PDF
Ab1320 Jak2 (v617f) Mutation and Association to Rheumatological Diseases Treatment. Study of 130 Patients From a Single University Hospital.
2022 · C. Álvarez-Reguera, L. Sanchez-Bilbao, et al. · Annals of the Rheumatic Diseases
PDF
Ab0825 Jak2 (v617f) Mutation and Association to Immune Mediated Diseases. Study of 130 Patients From a Single University Hospital
2021 · C. Álvarez-Reguera, L. Sanchez-Bilbao, et al. · Annals of the Rheumatic Diseases
PDF
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
2020 · Batlle-López, Ana, Grande, Carlos, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
El inhibidor de histonas deacetilasa romidepsina induce diferenciación en linfomas de origen centrogerminal a través de la regulación BCL6
2018 · Ana Batlle‐López, María G. Cortiguera, et al. · DIGITAL.CSIC (Spanish National Research Council (CSIC))
R‐comp Vs R‐chop as First‐line Therapy for Diffuse Large B ‐cell Lymphoma in Patients Older Than 60 Years: Results From a Randomized Phase 2 Study From the Spanish Geltamo Group
2017 · J. Sancho, F. Gual, et al. · Hematological Oncology
PDF
Regulation of BCL6 in aggressive B-cell lymphoma: Effects of epigenetic drugs
2017 · Lorena García-Gaipo, María G. Cortiguera, et al. · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Molecular characterization of the role of mitochondrial dysfunction in tumor development
2017 · Laura Quevedo, Thaidy Moreno-Rodriguez, et al. · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome
2014 · Paloma Ibarrondo, Andres Insunza, et al. · Blood
439: Effects of the histone deacetylase inhibitor romidepsin in lymphoma B-cells and BCL6 regulation
2014 · M.G. Cortiguera, L. García-Gaipo, et al. · European Journal of Cancer
Works count: 28
Citation count: 334
H-index: 10
I10-index: 10
Year
Topic
Type